MU
Mallikarjunachari Uppuladinne
Centre for Development of Advanced Computing, Indian Institute of Chemical Technology, Kakatiya University, BioMed Informatics, MNR Educational Trust
Employment
-
Centre for Development of Advanced Computing Joint Director2020 - Present
-
Centre for Development of Advanced Computing Principal Technical Officer2015 - 2020
-
Centre for Development of Advanced Computing Senior Technical Officer2011 - 2015
-
Centre for Development of Advanced Computing Technical Officer2008 - 2011
-
Indian Institute of Chemical Technology Project Assistant2006 - 2008
-
BioMed Informatics Research Associate2006 - 2006
Education
-
Indian Institute of Chemical Technology Advanced Course in Bioinformatics2005 - 2006
-
Kakatiya University M. Sc.2002 - 2004
-
MNR Educational Trust B.Sc.1999 - 2002
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- A novel approach to design chimeric multi epitope vaccine against Leishmania exploiting infected host cell proteome Save
- Pharmacophore-guided drug design using LdNMT as a model drug target for leishmaniasis. Save
- Probing the structure of human tRNA3Lys in the presence of ligands using docking, MD simulations and MSM analysis Save
- Phytochemicals from AYUSH-64 screened against main protease and spike protein of Omicron variant of SARS-CoV-2 using ensemble docking approach Save
- Structural insight into locked nucleic acid based novel antisense modifications: A DFT calculations at monomer and MD simulations at oligomer level. Save
- Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2. Save
- An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods. Save
- Structural insight into the binding interactions of NTPs and nucleotide analogues to RNA dependent RNA polymerase of SARS-CoV-2. Save
- Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro). Save
- Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. Save